CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at B. Riley from $33.00 to $42.00. They now have a "buy" rating on the stock.
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Guggenheim from $28.00 to $43.00. They now have a "buy" rating on the stock.
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program [Yahoo! Finance]
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Wells Fargo & Company from $30.00 to $35.00. They now have an "overweight" rating on the stock.
Form SCHEDULE 13D/A Centessa Pharmaceuticals Filed by: General Atlantic Cooperatief U.A.
Form 8-K Centessa Pharmaceuticals For: Nov 24
Form 424B5 Centessa Pharmaceuticals
Form 4 Centessa Pharmaceuticals For: Nov 17 Filed by: HUSSAIN IQBAL J
Form 4 Centessa Pharmaceuticals For: Nov 17 Filed by: Bush Tia L
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.